Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Pharmacokinetically guided dosing for intravenous melphalan: a pilot study in patients with advanced ovarian adenocarcinomaD Y Ploin, B Tranchand, J P Guastalla, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Pharmacokinetics and pharmacodynamics of nitrosourea fotemustine: a French cancer centre multicentric studyA Iliadis, M C Launay-Iliadis, C Lucas, et al.
British Journal of Clinical Pharmacology|May 19, 2007
Anti-factor Xa activity of enoxaparin administered at prophylactic dosage to patients over 75 years oldA Berges, S Laporte, M Epinat, et al.
Rapid Communications in Mass Spectrometry : RCM|August 2, 2005
Quantification of docetaxel and its main metabolites in human plasma by liquid chromatography/tandem mass spectrometryJ Guitton, S Cohen, B Tranchand, et al.
Investigational New Drugs|April 12, 2000
A sensitive docetaxel assay in plasma by solid-phase extraction and high performance liquid chromatography-UV detection: validation and suitability in phase I clinical trial pharmacokineticsC J Ardiet, B Tranchand, S Zanetta, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase I pharmacokinetics study of high-dose fotemustine and its metabolite 2-chloroethanol in patients with high-grade gliomasB Tranchand, C Lucas, P Biron, et al.
Therapeutic Drug Monitoring|January 1, 1990
Bayesian estimation of cyclosporine clearance in bone marrow graftF Serre-Debeauvais, A Iliadis, B Tranchand, et al.
British Journal of Clinical Pharmacology|August 23, 2007
Overview of model-building strategies in population PK/PD analyses: 2002-2004 literature surveyC Dartois, K Brendel, E Comets, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Clinical and pharmacokinetic phase II study of fotemustine in refractory and relapsing multiple myeloma patientsC Dumontet, J Jaubert, C Sebban, et al.
Cancer Chemotherapy and Pharmacology|January 27, 1998
Population pharmacokinetics of total and unbound etoposideL Nguyen, E Chatelut, C Chevreau, et al.
Pageof 3